Compare TARS & FRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TARS | FRME |
|---|---|---|
| Founded | 2016 | 1893 |
| Country | United States | United States |
| Employees | N/A | 2120 |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2020 | N/A |
| Metric | TARS | FRME |
|---|---|---|
| Price | $64.46 | $36.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $89.00 | $48.33 |
| AVG Volume (30 Days) | ★ 526.9K | 411.2K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.93% |
| EPS Growth | ★ 48.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $451,360,000.00 | N/A |
| Revenue This Year | $55.67 | $27.77 |
| Revenue Next Year | $30.64 | $5.87 |
| P/E Ratio | ★ N/A | $10.90 |
| Revenue Growth | ★ 146.71 | N/A |
| 52 Week Low | $38.51 | $33.29 |
| 52 Week High | $85.25 | $43.22 |
| Indicator | TARS | FRME |
|---|---|---|
| Relative Strength Index (RSI) | 37.12 | 33.32 |
| Support Level | $61.11 | $35.13 |
| Resistance Level | $67.70 | $37.03 |
| Average True Range (ATR) | 2.32 | 0.83 |
| MACD | -0.89 | -0.16 |
| Stochastic Oscillator | 3.08 | 15.63 |
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.